TY - JOUR T1 - VALIDATION OF PHLEBOTOMY PERFORMANCE METRICS DEVELOPED AS PART OF A PROFICIENCY BASED PROGRESSION INITIATIVE TO MITIGATE WRONG BLOOD IN TUBE JF - medRxiv DO - 10.1101/19010033 SP - 19010033 AU - N. O’ Herlihy AU - S Griffin AU - P Henn AU - R. Gaffney AU - M.R. Cahill AU - A.G. Gallagher Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/29/19010033.abstract N2 - Aims The purpose of this study was to 1) characterise the procedure of phlebotomy, deconstruct it into its constituent parts and develop a performance metric for the purpose of training healthcare professionals in a large teaching hospital, 2) evaluate the construct validity of the phlebotomy metric and establish a proficiency benchmark.Method Using video recordings of the procedure, we defined a performance metric. This was brought to a modified Delphi meeting, where consensus was reached by an expert panel. To demonstrate construct validity, we used the metric to objectively assess the performance of novices and expert practitioners.Results A phlebotomy metric consisting of 11 phases and 77 steps was developed. The mean inter-rater reliability was 0.91 (min 0.83, max 0.95). The Expert group completed more steps of the procedure (72 Vs 69), made 69% fewer errors (19 vs 13, p = 0.014) and 300% fewer critical errors (1 Vs 4, p = 0.002) than the Novice Group.Conclusions The metrics demonstrated construct validity and the proficiency benchmark was established with a minimum observation of 69 steps, with no critical errors and no more than 13 errors in total.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Cork University HospitalAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableWe shall make data available to the scientific community with as few restrictions as feasible. Data will be made available by contacting the corresponding author. ER -